A phase 2/3 randomized open-label multi-center study to determine the safety and efficacy of solithromycin in adolescents (12 to 17 years of age, inclusive) and children (> 2 months to < 12 years of age) with suspected or confirmed to community-acquired bacterial pneumonia (CABP),
Role: Investigator,
Cempra Pharmaceuticals,
(05/2017 - 05/2018)
Status: Completed
Internal
Databank of children and adolescents admitted to LLUCH for treatment of an eating disorder,
Role: Investigator,
LLU Dept. of Pediatrics,
(05/2020)
Status: Approved
Comparing creatinine in children and adolescents with eating disorders and elite athletes,
Role: Investigator,
LLU Dept. of Pediatrics,
(03/2020)
Status: Approved
Enteral ciprofloxacin and levofloxacin for ventilator-associated tracheobronchitis in infants and children,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(02/2020 - 06/2024)
Status: Completed
Single vs. combination anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) antibiotics for the treatment of complicated Pneumonia in pediatric patients: A retrospective analysis,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(11/2019 - 09/2024)
Status: Completed
Non-Profit Organization
Bronchiolitis in the ED: Low risk discharges and high-risk admission-virology sub-study,
Role: Investigator,
Emergency Medicine Foundation,
(12/2005 - 12/2006)
Status: Completed